Overview

Nebulized Versus Intravenous Dexmedetomidine for Sevoflurane Induced Emergence Agitation After Pediatric Tonsillectomy

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
0
Participant gender:
All
Summary
Pediatric patients undergoing tonsillectomy and adenoidectomy usually have a high incidence of postoperative EA, which increases the risk of developing postoperative airway obstruction and respiratory depression due to anatomical characteristics of operative location and increased susceptibility to opioid analgesics. the study will compare between nebulized and intravenous bolus of dexmedetomidine as a prophylaxis against postanesthetic emergence agitation in children undergoing tonsillectomy, adenoidectomy or adeno-tonsillectomy procedures.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- ASA I and II

- Children scheduled for tonsillectomy with or without adenoidectomy with or without
myringotomy, and/or tympanostomy tube insertion.

Exclusion Criteria:

- Patient's guardian refusal to participate in the study.

- Children with Behavioral changes; physical or developmental delay; neurological
disorder or psychological disorder.

- Children on sedative or anticonvulsant medication.

- history of sleep apnea

- significant organ dysfunction, cardiac dysrhythmia, congenital heart disease

- Known allergy to the study drugs.